Sign in

CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company

ASSEMBLY BIOSCIENCES, INC.

Sign in to watch
Ticker
ASMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(833) 409-4583
Business address
TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Former names
VENTRUS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$237,648
in 4 filings

Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 89 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-23 McHutchison John G Director Sale −2,117 $14.93 $32K 19,104
2024-05-23 Okazaki Jason A CEO and President Sale −549 $14.93 $8K 16,082
2024-05-23 White Nicole S Chief Manufacturing Officer Sale −172 $14.93 $3K 12,853
2024-04-30 White Nicole S Chief Manufacturing Officer Sale −1,255 $12.71 $16K 13,025
2024-04-30 Okazaki Jason A CEO and President Sale −1,569 $12.71 $20K 16,423
2024-04-29 White Nicole S Chief Manufacturing Officer Grant or award +3,333 14,280
2024-04-29 Okazaki Jason A CEO and President Grant or award +4,166 17,992
2024-04-29 Delaney William E IV Chief Scientific Officer Grant or award +3,333 16,109
2024-04-01 McHutchison John G Director Sale −1,206 $13.07 $16K 21,221
2024-04-01 Bjorkquist Jeanette M Principal Accounting Officer Sale −114 $13.07 $1K 3,166
2024-04-01 White Nicole S Chief Manufacturing Officer Sale −197 $13.07 $3K 10,947
2024-04-01 Okazaki Jason A CEO and President Sale −354 $13.07 $5K 13,826
2024-03-29 Bjorkquist Jeanette M Principal Accounting Officer Grant or award +850 3,280
2024-03-29 Bjorkquist Jeanette M Principal Accounting Officer Grant or award · Stock Option (right to buy) +1,550 1,550
2024-03-29 White Nicole S Chief Manufacturing Officer Grant or award · Stock Option (right to buy) +17,500 17,500
2024-03-29 Delaney William E IV Chief Scientific Officer Grant or award · Stock Option (right to buy) +20,000 20,000
2024-03-29 Okazaki Jason A CEO and President Grant or award · Stock Option (right to buy) +65,000 65,000
2024-03-27 Okazaki Jason A CEO and President Sale −392 $12.87 $5K 14,180
2024-01-18 Schornstein Alexander 10% owner Purchase +345,086 $0.80 $276K 8,209,372
2024-01-17 Schornstein Alexander 10% owner Purchase +299,994 $0.78 $235K 7,864,286

Page 5 of 15 · 297 trades